|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 102 TWD | +5.48% |
|
+3.45% | +16.04% |
Diamond Biotechnology Co., Ltd reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 616.1 million compared to TWD 434.84 million a year ago. Net income was TWD 46.74 million compared to TWD 33.39 million a year ago.
Basic earnings per share from continuing operations was TWD 1.7 compared to TWD 1.21 a year ago. Diluted earnings per share from continuing operations was TWD 1.7 compared to TWD 1.21 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +16.04% | 86.3M | |
| -5.60% | 181B | |
| -4.45% | 101B | |
| -4.15% | 67.54B | |
| -8.63% | 45.09B | |
| +9.70% | 44.37B | |
| +7.23% | 40.7B | |
| +15.22% | 29.85B | |
| +13.02% | 24.49B | |
| -6.46% | 23.99B |
DIAMOND BIOTECHNOLOGY CO., LTD 
